Adverse events following third dose of mRNA COVID-19 vaccination among nursing home residents who received the primary series.

ABSTRACT:

Background

We sought to compare rates of adverse events among nursing home residents who received an mRNA COVID-19 vaccine booster dose with those who had not yet received their booster.

Methods

We assessed a prospective cohort of 11,200 nursing home residents who received a primary COVID-19 mRNA vaccine series at least 6 months prior to September 22, 2021 and received a third "booster dose" between September 22, 2021 and February 2, 2022. Residents lived in 239 nursing homes operated by Genesis HealthCare, spanning 21 U.S. states. We screened electronic health records for 20 serious vaccine-related adverse events that are monitored following receipt of COVID-19 vaccination by the CDC's Vaccine Safety Datalink. We matched boosted and yet-to-be boosted residents during the sa

SUBMITTER: Bardenheier BH 

PROVIDER: S-EPMC9115078 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature